1.
J Pediatric Infect Dis Soc
; 11(12): 590-593, 2022 Dec 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36112393
RESUMO
Forty-nine of 52 (94.2%) children with musculoskeletal infection (MSKI) were successfully treated with cefadroxil dosed at 30 mg/kg/day over a 10-year time period. Two failures were associated with poor medication adherence. Our study suggests that treatment of MSKI with cefadroxil offers acceptable outcomes. Confirmation through clinical trials is appropriate.